Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Gurnari C, Nautiyal I, Pagliuca S

Therapeutics and Clinical Risk Management 2021, 17:1343-1351

Published Date: 14 December 2021